The clinic offers treatment of arteriosclerosis with intravenous EDTA, including claudicatio intermittens, window shopper syndrome, smoker’s leg, stents, balloon expansions, heart cramps, angina pectoria, arteriosclerosis in the retina, complications from diabetes/sugar disease, and others.

Here is a link where doctor Claus Hancke informs about EDTA-treatment.

And here is a link where doctor Knut Flytlie describes an research result.

The body is infused with a sterile fluid containing EDTA (see below), vitamin C, magnesium, and sodium bicarbonate over a 3-hour period. This takes place in a comfortable chair with the possibility for rest, reading, sleep, or work via our WiFi. The treatment is not associated with discomfort, and you can subsequently return to work or engage in leisure activities. Depending on age and the severity of the disease, approximately 30 treatments are required. The treatment can be given 1 to 2 times a week. After achieving satisfactory results, we prefer to switch to a maintenance treatment, initially about once every 14 days and later once a month.


EDTA is a weak amino acid that is capable of binding metal ions, such as lead, iron, copper, aluminum, and calcium, in the order of attraction mentioned. EDTA thus detoxifies the body of heavy metals before helping with arteriosclerosis. That is, the treatment’s effect on arteriosclerosis depends on the patient’s degree of heavy metal poisoning. Experience shows that it takes 12 to 25 treatments for the full effect to take effect on arteriosclerosis.

Dentists use the calcium binding effect to expand the root canal before a root treatment. Laboratory doctors have for decades utilized the calcium binding and blood-thinning effect of the substance: EDTA is added to blood test tubes to prevent blood from coagulating. EDTA is on hospital emergency rooms ready to treat lead poisoning.

EDTA has a healing effect on various other diseases, which was discovered by chance. When treating a larger group of lead-poisoned workers at a battery factory in Michigan, USA in 1950, doctors discovered that chronic diseases disappeared or became less bothersome, including heart and circulation problems. Enthusiastic American doctors developed a protocol for EDTA chelation therapy in the following years, but after the expiration of the patent, there was no positive interest in either the substance or the principle in the pharmaceutical industry. Many patients feel so good that they can entirely or partially do without medication.

A Danish survey of 470 EDTA-treated patients (published in the USA by Hancke and Flytlie in 1993), showed a good effect on 85% of the patients. Of the 65 who came from the waiting list for expensive by-pass operations, 58 avoided the operation. Of the 27 with imminent leg amputation, 24 avoided losing one leg. An American review of 19 scientific studies of EDTA (meta-analysis) from the same year, covering 22,765 patients, also showed good results in 88% of patients.

Subsidized by: The public health insurance

As a member of group 2 (read more:) group 2 in the public health insurance, you can get a reimbursement of approximately DKK 200 per treatment invoice (0101 consultation). However, you must submit the receipted invoice to your regional billing office.

Subsidy from: Sygekassen Danmark

As a member of group 2 in Sygekassen Danmark, you can get a reimbursement of approximately DKK 80 per treatment invoice (0101 consultation).

However, you must submit the receipted invoice to Sygekassen Danmark.

1. C. Hancke, K. Flytlie: Benefits of EDTA Chelation Therapy in Arteriosclerosis: A Retrospectiv Study of 470 Patients. J of Advancement in Medicin, 6; 161-171. 1993.
2. L. T. Chappel, J. P. Stahl: The correlation between EDTA Chelation Therapy and Improvement in Cardiovascular Function: A Meta-Analysis. JAM, 3; 139-159. 1993.
3. E. M. Cranton: A Textbook on EDTA Chelation Therapy. Human Sciences Press, New York, USA. 1989.
4. F. H. Messerli: Cardiovascular Drug Therapy: Magnesium EDTA Chelation. W. B. Saunders Company, Philadelphia, USA. 2; 1613-1617. 1996.
5. E. M. Cranton: Bypassing Bypass, the new Technique of Chelation Therapy. Hampton Roads, USA. 1992.
6. P. Fernlund, A. Hanson, C. Laurell, B. Lundh: Klinisk Kemi. Studentlitteratur, Lund, Sverige. 1986.
7. Bruce W. Halstead: The scientific Basis of EDTA Chelation Therapy. Golden Quill Publishers, Colton, USA. 1979.
8. E. M. Cranton: Textbook on EDTA Chelation Therapy, Second Edition. April 2001.
9. Cardiovascular Drug Therapy, Textbook Second Edition, W. B. Saunders Company, s. 1612-1617
youtube links: